Nutex Health, Inc. (NUTX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
NUTX currently has 6.99M outstanding shares. with minimal authorized share overhang for future dilution. The company has significantly diluted shareholders by 881.91% over the past 2 years, indicating aggressive capital raising. Recent corporate actions include 2 stock splits (positive for accessibility) and 2 reverse splits (concerning signal).
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Apr 30, 2026 |
10-Q filing | 7.0M shares outstanding |
7M | 0 |
| Nov 19, 2025 |
10-Q filing | 7.2M shares outstanding |
7.2M | 0 |
| Nov 18, 2025 |
10-Q filing | 7.1M shares outstanding |
7.1M | 0 |
| May 13, 2025 |
10-Q filing | 5.5M shares outstanding |
5.5M | 0 |
| Apr 23, 2025 |
S-3/A filing: This S-3/A filing relates to the resale of up to 78,424 shares of Nutex Health Inc.'s common stock issuable upon exercise of warrants by the selling securityholders. |
5.5M | 0 |
| Apr 15, 2025 |
S-3 filing: Nutex Health Inc. files an S-3 to register the resale of up to 78,424 shares of common stock issuable upon exercise of warrants by selling securityholders. |
5.5M | 0 |
| Mar 31, 2025 |
10-K filing | 5.5M shares outstanding |
5.5M | 0 |
| Nov 07, 2024 |
10-Q filing | 5.4M shares outstanding |
5.4M | 0 |
| Aug 08, 2024 |
10-Q filing | 4.5M shares outstanding |
4.5M | 0 |
| Jul 03, 2024 |
Stock Split
8-K filing: Stock split 1-for-10 | Outstanding: 4,849,234 → 484,923 |
480K | 130K |
| Jul 02, 2024 |
Stock Split
8-K filing: Stock split 1-for-10 | Outstanding: 48,492,347 → 4,849,234 |
4.8M | 1.3M |
| May 09, 2024 |
10-Q filing | 48.5M shares outstanding |
48M | 13M |
| Apr 09, 2024 |
Stock Split
8-K filing: Stock split 1-for-15 | Outstanding: 661,247,959 → 44,083,197 |
44M | 17M |
| Mar 29, 2024 |
10-K filing | 661.2M shares outstanding |
660M | 260M |
| Jan 24, 2024 |
8-K filing: Nutex Health Inc. entered into a Securities Purchase Agreement for the sale of 66,666,666 shares of common stock and warrants to purchase 66,666,666 shares at a price of $0.15 per share and warrant, with gross proceeds expected to be approximately $10 million. ($10.0M proceeds) |
670M | 260M |
| Nov 09, 2023 |
10-Q filing | 665.1M shares outstanding |
670M | 260M |
| Aug 09, 2023 |
10-Q filing | 656.6M shares outstanding |
660M | 260M |
| May 15, 2023 |
10-Q filing | 650.9M shares outstanding |
650M | 270M |
| Mar 28, 2023 |
S-3 filing: Nutex Health Inc. files an S-3 form to register the offering of Common Stock, Senior Debt Securities, Subordinated Debt Securities, Warrants, and Rights, with an aggregate offering price of up to $300,000,000. |
630M | 290M |
| Mar 10, 2023 |
POS AM filing: This is a POS AM filing for Nutex Health Inc. relating to the resale of 196,139,751 shares of common stock by selling stockholders. |
630M | 0 |
| Mar 03, 2023 |
10-K filing | 634.9M shares outstanding |
630M | 0 |
| Nov 21, 2022 |
10-Q filing | 649.6M shares outstanding |
650M | 0 |
| Nov 18, 2022 |
8-K filing: Nutex Health Inc. entered into a purchase agreement with Lincoln Park Capital Fund, LLC, allowing Nutex Health to sell up to $100 million worth of its common stock over a 36-month term. Nutex Health also issued 1,356,318 shares of Common Stock to the Investor as a commitment fee. |
650M | 0 |
| Aug 22, 2022 |
10-Q filing | 646.4M shares outstanding |
650M | 0 |
| May 13, 2022 |
10-Q filing | 645.4M shares outstanding |
650M | 0 |
| Mar 31, 2022 |
10-K filing | 48.4M shares outstanding |
48M | 0 |
| Nov 15, 2021 |
10-Q filing | 48.0M shares outstanding |
48M | 0 |
| Oct 01, 2021 |
8-K filing: Clinigene Holdings, Inc. completed a private placement transaction with Apollo Medical Holdings, Inc. on September 30, 2021, issuing 1,000,000 shares of common stock at $3.00 per share and warrants to purchase an additional 500,000 shares at $3.50 per share, resulting in ApolloMed nominating one person to Clinigence's Board of Directors. ($3.0M proceeds) |
42M | 0 |
| Aug 16, 2021 |
10-Q filing | 42.0M shares outstanding |
42M | 0 |
| May 24, 2021 |
10-Q filing | 40.8M shares outstanding |
41M | 0 |
| May 24, 2021 |
8-K filing: Clinigence Holdings, Inc. entered into a Letter of Intent to acquire Procare Health Inc. by issuing approximately 759,036 newly issued shares of common stock to the equity holders of Procare in exchange for 100% of the outstanding equity securities of Procare. |
39M | 0 |
| Apr 05, 2021 |
10-K filing | 39.3M shares outstanding |
39M | 0 |
| Nov 16, 2020 |
10-Q filing | 5.3M shares outstanding |
5.3M | 0 |
| Jun 29, 2020 |
10-Q filing | 4.6M shares outstanding |
4.6M | 0 |
| May 14, 2020 |
10-K filing | 4.6M shares outstanding |
4.6M | 0 |